US10730889, Example 244;N-[[6-[4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]benzoyl]-6-azaspiro[2.5]octan-2-yl]methyl]furo[2,3-c]pyridine-2-carboxamide
CAS
1453270-57-9
化学式
C27H27N5O5
mdl
——
分子量
501.542
InChiKey
IMVNGSMVDQQQKE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
物化性质
计算性质
ADMET
安全信息
SDS
制备方法与用途
上下游信息
反应信息
文献信息
表征谱图
同类化合物
相关功能分类
相关结构分类
计算性质
辛醇/水分配系数(LogP):
3.1
重原子数:
37
可旋转键数:
7
环数:
6.0
sp3杂化的碳原子比例:
0.37
拓扑面积:
124
氢给体数:
1
氢受体数:
8
文献信息
[EN] AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS SULFONAMIDES ET AMIDES AMIDO-SPIROCYCLIQUES
申请人:GENENTECH INC
公开号:WO2013127269A1
公开(公告)日:2013-09-06
Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES
申请人:GENENTECH, INC.
公开号:US20160002266A1
公开(公告)日:2016-01-07
Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
本发明提供了含有螺环酰胺和磺酰胺化合物的药物组合物,以及使用这些化合物的治疗方法。
Amido spirocyclic amide and sulfonamide derivatives
申请人:Forma TM, LLC
公开号:US10730889B2
公开(公告)日:2020-08-04
Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.